OraSure Technologies Inc. of Bethlehem, the company that created the first over-the-counter oral HIV test, has reported record earnings for 2013 and for the fourth quarter of last year.
The company said consolidated revenue for the fourth quarter was $28.8 million, a 30 percent increase over the same quarter in 2012. For the year, the company took in $98.9 million, a 13 percent increase over 2012.
The company said the increases were primarily a result of sales of the company’s OraQuick in-home HIV test, and higher revenue from the company’s molecular collection system’s subsidiary, DNA Genotek.
Gross sales of the company’s OraQuick In-Home HIV test were $4.3 million for the fourth quarter and $9.9 million for the full-year 2013.
“Our molecular collection systems business was particularly strong, growing by more than 40 percent for the year,” said Douglas A. Michels, president and CEO of OraSure Technologies. “Infectious disease revenues also increased largely due to contributions from our newest products, the OraQuick In-Home HIV test and the OraQuick rapid HCV test.”